Toru Naganuma

Toru Naganuma

Auto-generated profile, based on publicly available information

Toru Naganuma

Center for Innovative Research for Communities and Clinical Excellence (CIRC2LE), Fukushima Medical University, Fukushima, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2008 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
TNToru Naganuma
Toru Naganuma
SKShinichi Kuriyama
Shinichi Kuriyama
MKMasako Kakizaki
Masako Kakizaki
TSToshimasa Sone
Toshimasa Sone
NNNaoki Nakaya
Naoki Nakaya
ITIchiro Tsuji
Ichiro Tsuji
An inverse association between coffee consumption and the risk of oral, pharyngeal, and esophageal cancers has been suggested in case-control studies, but few results from prospective studies are available. Data from the Miyagi Cohort Study in Japan were used to clarify the association between coffee consumption and the risk of these cancers. Information about coffee consumption was obtained from self-administered food frequency questionnaires in 1990. Among 38,679 subjects aged 40–64 years with no previous history of cancer, 157 cases of oral, pharyngeal, and esophageal cancers were identified during 13.6 years of follow-up. Hazard ratios were estimated by the Cox proportional hazards regression model. The risk of oral, pharyngeal, and esophageal cancers was inversely associated with coffee consumption. The multivariate-adjusted hazard ratio of these cancers for ≥1 cups of coffee per day compared with no consumption was 0.51 (95% confidence interval: 0.33, 0.77). This inverse association was consistent regardless of sex and cancer site and was observed both for subjects who did not drink or smoke and for those who currently drank or smoked at baseline. In conclusion, coffee consumption was associated with a lower risk of oral, pharyngeal, and esophageal cancers, even in the group at high risk of these cancers.

30 January 2007 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
TNToru Naganuma
Toru Naganuma
SKShinichi Kuriyama
Shinichi Kuriyama
MAMunira Akhter
Munira Akhter
MKMasako Kakizaki
Masako Kakizaki
NNNaoki Nakaya
Naoki Nakaya
ITIchiro Tsuji
Ichiro Tsuji
An inverse association between coffee consumption and the risk of colorectal cancer has been reported in several case–control studies, but results from prospective cohort studies have been inconclusive. We conducted a prospective cohort study among a Japanese population to clarify the association between coffee consumption and the risk of colorectal cancer incidence. We used data from the Miyagi Cohort Study for this analysis. Usable self‐administered questionnaires about coffee consumption were returned from 22,836 men and 24,769 women, aged 40–64 years, with no previous history of cancer. We used the Cox proportional‐hazard regression model to estimate hazard ratios and 95% confidence intervals. During 11.6 years of follow‐up (425,303 person‐years), we identified 457 cases of colorectal cancer. Coffee consumption was not associated with the incidence of colorectal, colon or rectal cancer. The multivariate‐adjusted hazard ratio (95% confidence interval) of colorectal cancer incidence for 3 or more cups of coffee per day as compared with no consumption was 0.95 (0.65–1.39) for men and women (p for trend = 0.55), 0.91 (0.56–1.46) for men (p for trend = 0.53) and 1.16 (0.60–2.23) for women (p for trend = 0.996). Coffee consumption was also not associated with incidence of either proximal or distal colon cancer. We conclude that coffee consumption is not associated with the incidence risk of colorectal cancer in the general population in Japan.

26 June 2023 in Innovation in Aging
Verified
Journal Article
Open access
PDF file
STSei Takahashi
Sei Takahashi
TNToru Naganuma
Toru Naganuma
NKNoriaki Kurita
Noriaki Kurita
KOKenji Omae
Kenji Omae
TOTsuyoshi Ohnishi
Tsuyoshi Ohnishi
RTRyoji Tominaga
Ryoji Tominaga
Background and Objectives: The relationship between social isolation/loneliness and oral health is unclear. This study investigated the association between social isolation/loneliness and tooth loss in older Japanese adults. Research Design and Methods: This was a cross-sectional study of a population-based cohort (the Sukagawa Study); 5,490 cohort study participants aged ≥75 years and who were independent answered a self-administered questionnaire in 2018. Social isolation was defined based on the 6-item Japanese version of the Lubben Social Network Scale. Loneliness was measured by the 3-item Japanese version of the University of California, Los Angeles (UCLA) Loneliness Scale version 3. The primary outcome was tooth loss, defined as having fewer than 20 teeth. The secondary outcomes were decreased toothbrushing frequency and diminished ability to chew food. Prevalence ratios (PRs) were estimated using a modified Poisson regression analysis in 2 models—Model 1, which adjusted for age, gender, smoking status, alcohol consumption, low annual income, and short education period, and Model 2, which added history of depression, history of diabetes mellitus, history of stroke, and cognitive impairment to Model 1. Results: The primary analysis included 5,490 participants. Adjusted PRs of social isolation and loneliness for tooth loss (Model 1) were 0.97 (95% confidence interval [CI] 0.93–1.01) and 1.07 (95% CI 1.02–1.12), respectively; those for decreased toothbrushing frequency were 1.17 (95% CI 0.98– 1.39) and 1.59 (95% CI 1.30–1.93), respectively; and those for chewing difficulty were 1.65 (95% CI 1.12–2.43) and 3.01 (95% CI 2.02–4.51), respectively. The adjusted PRs in Model 2 demonstrated results similar to that of Model 1. Discussion and Implications: Loneliness is associated with tooth loss among older adults, whereas social isolation is not. Our findings can inform plans for policymakers, professionals, and organizations to identify lonely older adults and provide social prescriptions to improve their access to oral health care services.

29 July 2009 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
TNToru Naganuma
Toru Naganuma
SKShinichi Kuriyama
Shinichi Kuriyama
MKMasako Kakizaki
Masako Kakizaki
TSToshimasa Sone
Toshimasa Sone
NNNaoki Nakaya
Naoki Nakaya
ITIchiro Tsuji
Ichiro Tsuji
Several biologic studies have reported that green tea constituents have antitumor effects on hematologic malignancies. However, the effects in humans are uncertain. The authors used data from the Ohsaki National Health Insurance Cohort Study in Japan to evaluate the association between green tea consumption and the risk of hematologic malignancies. Study participants were 41,761 Japanese adults aged 40–79 years without a history of cancer at baseline who answered a food frequency questionnaire survey in 1994. During 9 years of follow-up beginning in 1995, the authors documented 157 hematologic malignancies, including 119 cases of lymphoid neoplasms and 36 cases of myeloid neoplasms. Hazard ratios were calculated by using the Cox proportional hazards regression model. Risk of hematologic malignancies was inversely associated with green tea consumption. The multivariate-adjusted hazard ratio of hematologic malignancies for 5 cups/day or more compared with less than 1 cup/day of green tea was 0.58 (95% confidence interval: 0.37, 0.89). The corresponding risk estimate was 0.52 (95% confidence interval: 0.31, 0.87) for lymphoid neoplasms and 0.76 (95% confidence interval: 0.32, 1.78) for myeloid neoplasms. This inverse association was consistent across sex and body mass index strata. In conclusion, green tea consumption was associated with a lower risk of hematologic malignancies.

22 August 2019 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
KOKenji Omae
Kenji Omae
YYYosuke Yamamoto
Yosuke Yamamoto
NKNoriaki Kurita
Noriaki Kurita
TTTaro Takeshima
Taro Takeshima
TNToru Naganuma
Toru Naganuma
SFShunichi Fukuhara
Shunichi Fukuhara

11 June 2024 in BMC Medicine
Verified
Journal Article
Open access
PDF file
TATetsuro Aita
Tetsuro Aita
HNHiroaki Nakagawa
Hiroaki Nakagawa
STSei Takahashi
Sei Takahashi
TNToru Naganuma
Toru Naganuma
KAKeisuke Anan
Keisuke Anan
SHSugihiro Hamaguchi
Sugihiro Hamaguchi
Background: Accurate prediction of bacteremia is essential for guiding blood culture collection and optimal antibiotic treatment. Shaking chills, defined as a subjective chill sensation with objective body shivering, have been suggested as a potential predictor of bacteremia; however, conflicting findings exist. To address the evidence gap, we conducted a systematic review and meta-analysis of studies to assess the diagnostic accuracy of shaking chills for predicting bacteremia among adult patients. Methods: We included studies reporting the diagnostic accuracy of shaking chills or chills for bacteremia. Adult patients with suspected bacteremia who underwent at least one set of blood cultures were included. Our main analysis focused on studies that assessed shaking chills. We searched these studies through CENTRAL, MEDLINE, Embase, the World Health Organization ICTRP Search Portal, and ClinicalTrials.gov. Study selection, data extraction, evaluation for risk of bias, and applicability using the QUADAS-2 tool were conducted by two independent investigators. We estimated a summary receiver operating characteristic curve and a summary point of sensitivity and specificity of the index tests, using a hierarchical model and the bivariate model, respectively. Results: We identified 19 studies with a total of 14,641 patients in which the accuracy of shaking chills was evaluated. The pooled sensitivity and specificity of shaking chills were 0.37 (95% confidence interval [CI], 0.29 to 0.45) and 0.87 (95% CI, 0.83 to 0.90), respectively. Most studies had a low risk of bias in the index test domain and a high risk of bias and a high applicability concern in the patient-selection domain. Conclusions: Shaking chills are a highly specific but less sensitive predictor of bacteremia. Blood cultures and early initiation of antibiotics should be considered for patients with an episode of shaking chills; however, the absence of shaking chills must not lead to exclusion of bacteremia and early antibiotic treatment.